United States - English - NLM (National Library of Medicine)

physician therapeutics llc - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine hydrochloride 10 mg - fluoxetine is indicated for the acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to18 years [see clinical studies (14.1) ]. the usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods should periodically be re-evaluated [see dosage and administration (2.1) ]. fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder (ocd)  [see clinical studies (14.2) ]. the effectiveness of fluoxetine in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. therefore, the physician who elects to use fluoxetine for extended periods, should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see dosage and administration (2.2) ]. fluoxetine is indicated for the acute and maintenance treatment of bi

Canada - English - Health Canada

biologische heilmittel heel gmbh - yucca filamentosa - liquid - 10d - yucca filamentosa 10d - homeopathic products

Canada - English - Health Canada

biologische heilmittel heel gmbh - yucca filamentosa - liquid - 6d - yucca filamentosa 6d - homeopathic products

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram hydrobromide 10 mg - indications and usage citalopram tablets are indicated for the treatment of depression.   the efficacy of citalopram tablets in the treatment of depression was established in 4-6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the dsm-iii and dsm-iii-r category of major depressive disorder (see clinical pharmacology).   a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms:  depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation.   the antidepressant action of citalopram tablets in hospitalized depressed patients has not been

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine hydrochloride 150 mg - ranitidine tablets, usp is indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). 4. short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have b

Canada - English - Health Canada

homeocan inc. - yucca filamentosa - tablet - 1dh - yucca filamentosa 1dh - homeopathic products

Canada - English - Health Canada

dolisos canada inc. - yucca filamentosa - globules - 1x - yucca filamentosa 1x - homeopathic products

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 58865 - vascular introducer kit - the sentrant? introducer sheath is comprised of 2 components: a dilator and an introducer sheath which accommodate a 0.89mm guidewire. the dilator is radiopaque and has a tapered, flexible tip that facilitates atraumatic tracking through the vasculature. the introducer sheath is comprised of a hydrophilic, coil-reinforced catheter that is attached to a rigid seal housing containing the hemostatic valve assembly. the intended use of the sentrant introducer sheath is to provide a conduit for the insertion of diagnostic or endovascular devices into the vasculature.

United States - English - NLM (National Library of Medicine)

bhp holdings, inc. - angelica archangelica root (unii: dtn01m69sn) (angelica archangelica root - unii:dtn01m69sn), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), yucca filamentosa (unii: t6vr38uj9i) (yucca filamentosa - unii:t6vr38uj9i), sus scrofa cartilage (unii: 73ecw5wg2f) (sus scrofa cartilage - unii:73ecw5wg2f), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), toxicodendron pubescens - supports the immune system for host resistance to lyme disease and co-infections. supports the immune system for host resistance to lyme disease and co-infections.

United States - English - NLM (National Library of Medicine)

bhp holdings, inc. - angelica archangelica root (unii: dtn01m69sn) (angelica archangelica root - unii:dtn01m69sn), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), yucca filamentosa whole (unii: t6vr38uj9i) (yucca filamentosa - unii:t6vr38uj9i), sus scrofa cartilage (unii: 73ecw5wg2f) (sus scrofa cartilage - unii:73ecw5wg2f), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), toxicodendron pube - supports the immune system. formulated and produced under the guidelines of the homeopathic pharmacopoeia of the united states. supports the immune system. formulated and produced under the guidelines of the homeopathic pharmacopoeia of the united states.